What are Aurinia Pharmaceuticals's profit margins?

Aurinia Pharmaceuticals (AUPH) runs a 89.7% gross margin and a 41.7% operating margin, with a 100.0% net margin.

Where do Aurinia Pharmaceuticals's ratios come from?

Every ratio is computed from Aurinia Pharmaceuticals's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.

Aurinia Pharmaceuticals AUPH Ratios & Valuation

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	Q1 '26	Q4 '25	Q3 '25	Q2 '25	Q1 '25
Profitability
Gross margin	89.7%+1.3pp	88.5%-0.5pp	88.9%-0.6pp	89.5%+1.3pp	88.2%+0.3pp
Operating margin	41.7%+4.7pp	37.1%+10.7pp	26.3%+6.3pp	20%+7.7pp	12.3%+14.3pp
Net margin	100%-1.5pp	101.5%+72.2pp	29.3%+6.0pp	23.3%+7.2pp	16.1%+13.7pp
EBITDA margin	48.2%+4.3pp	43.9%+10.3pp	33.7%+6.2pp	27.5%+7.3pp	20.2%+13.9pp
Returns
Return on equity	65%+5.1pp	59.9%+39.3pp	20.7%+3.3pp	17.3%+6.1pp	11.2%+9.7pp
Return on assets	48.5%+4.4pp	44.1%+29.7pp	14.5%+2.6pp	11.8%+4.0pp	7.8%+6.8pp
Return on invested capital	25.2%+3.8pp	21.4%+4.8pp	16.7%+3.8pp	12.8%+5.0pp	7.9%+9.0pp
Efficiency
Asset turnover	0.5×+0.1×	0.4×-0.1×	0.5×0.0×	0.5×0.0×	0.5×+0.1×
Inventory turnover	0.7×-0.1×	0.8×+0.1×	0.7×+0.1×	0.6×0.0×	0.7×0.0×
Liquidity
Current ratio	5.5×+0.3×	5.2×-0.5×	5.8×+0.5×	5.2×-0.7×	5.9×+1.4×
Quick ratio	5×+0.3×	4.8×-0.4×	5.2×+0.5×	4.6×-0.6×	5.3×+1.1×
Cash ratio	0.5×-0.4×	0.9×-0.1×	1×+0.3×	0.7×-0.3×	1×+0.1×
Leverage
Debt-to-equity	0.2×0.0×	0.2×-0.1×	0.3×0.0×	0.3×0.0×	0.3×0.0×
Debt-to-assets	0.1×0.0×	0.1×-0.1×	0.2×0.0×	0.2×0.0×	0.2×0.0×
Net debt / EBITDA	0.3×+0.2×	0.1×-0.1×	0.2×-0.4×	0.6×+0.1×	0.5×-0.2×
Interest coverage	29.1×+4.9×	24.2×+8.4×	15.8×+4.3×	11.5×+4.9×	6.6×+7.6×
Per Share
Book value per share	$4.12-1.6%	$4.19+55.9%	$2.69+10.3%	$2.44-0.3%	$2.45-5.3%
Valuation
Market capitalization	$1.97B-6.3%	$2.1B+44.6%	$1.45B+33.7%	$1.09B-1.5%	$1.1B-14.1%
Enterprise value	$2.01B-4.7%	$2.11B+43.2%	$1.48B+30.3%	$1.13B+0.2%	$1.13B-12.8%
Price / earnings	6.6×-0.7×	7.3×-11.4×	18.7×+0.8×	17.9×-9.8×	27.7×-196×
Price / sales	6.6×-0.8×	7.4×+2.0×	5.5×+1.3×	4.2×-0.3×	4.5×-1.0×
Price / book	3.5×-0.1×	3.6×-0.4×	4×+0.7×	3.2×+0.1×	3.2×-0.3×
EV / EBITDA	14×-3.0×	17×+0.5×	16.5×+0.7×	15.8×-6.8×	22.7×-65.1×
EV / sales	6.8×-0.7×	7.5×+1.9×	5.6×+1.2×	4.4×-0.2×	4.6×-0.9×
Earnings yield	15.1%+1.5pp	13.7%+8.3pp	5.4%-0.2pp	5.6%+2.0pp	3.6%+3.2pp
PEG ratio	0×0.0×	0×—	——	——	——

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are Aurinia Pharmaceuticals's profit margins?: Aurinia Pharmaceuticals (AUPH) runs a 89.7% gross margin and a 41.7% operating margin, with a 100.0% net margin.
Where do Aurinia Pharmaceuticals's ratios come from?: Every ratio is computed from Aurinia Pharmaceuticals's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.